Connor, Clark & Lunn Investment Management (CC&L)’s Roivant Sciences ROIV Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-372,556
| Closed | -$3.93M | – | 1648 |
|
|
2024
Q1 | $3.93M | Sell |
372,556
-526,410
| -59% | -$5.55M | 0.02% | 488 |
|
|
2023
Q4 | $10.1M | Buy |
898,966
+120,001
| +15% | +$1.35M | 0.05% | 272 |
|
|
2023
Q3 | $9.1M | Buy |
778,965
+643,343
| +474% | +$7.51M | 0.05% | 268 |
|
|
2023
Q2 | $1.37M | Buy |
+135,622
| New | +$1.37M | 0.01% | 706 |
|